AJANTPHARM.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:00):

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages...

Stats
Tagesvolumen	205 248
Durchschnittsvolumen	116 878
Marktkapitalisierung	276.20B
EPS	INR0 ( 2024-04-26 )
Nächstes Ertragsdatum	( INR23.80 ) 2024-05-02
Last Dividend	INR15.00 ( 2023-08-04 )
Next Dividend	INR0 ( N/A )
P/E	37.73
ATR14	INR4.20 (0.19%)

Volumen Korrelation

Lang: 0.72 (moderate)

Kurz: 0.53 (weak)

Signal:(68.501) Neutral

Ajanta Pharma Limited Korrelation

10 Am meisten positiv korreliert
BHARATWIRE.NS	0.837
IZMO.NS	0.823
ASHIANA.NS	0.821
ASIANHOTNR.NS	0.805
AUROPHARMA.NS	0.801
GISOLUTION.NS	0.801

10 Am meisten negativ korreliert
STARTECK.NS	-0.829
SEYAIND.NS	-0.806

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Ajanta Pharma Limited Korrelation - Währung/Rohstoff

-0.11
( neutral )

-0.29
( neutral )

-0.18
( neutral )

-0.29
( neutral )

0.14
( neutral )

0.19
( neutral )

Ajanta Pharma Limited Finanzdaten

Annual	2022
Umsatz:	INR37.43B
Bruttogewinn:	INR26.92B (71.93 %)
EPS:	INR45.89

FY	2022
Umsatz:	INR37.43B
Bruttogewinn:	INR26.92B (71.93 %)
EPS:	INR45.89

FY	2022
Umsatz:	INR32.84B
Bruttogewinn:	INR23.97B (73.00 %)
EPS:	INR54.97

FY	2021
Umsatz:	INR28.47B
Bruttogewinn:	INR21.65B (76.03 %)
EPS:	INR50.06

Financial Reports:

No articles found.

Ajanta Pharma Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR7.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR15.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Ajanta Pharma Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.37 - low (12.11%) | Divividend Growth Potential Score: 5.25 - Stable (4.94%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.133	2002-12-17
Last Dividend	INR15.00	2023-08-04
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	INR73.42	--
Avg. Dividend % Per Year	0.57%	--
Score	2.22	--
Div. Sustainability Score	3.37
Div.Growth Potential Score	5.25
Div. Directional Score	4.31	--

Next Divdend (Est)
(2024-08-29)

INR16.81 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.22

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR6.00	0.78%
2019	INR8.67	1.10%
2020	INR6.33	0.97%
2021	INR6.33	0.58%
2022	INR7.00	0.47%
2023	INR15.00	1.24%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RPPL.NS	Dividend Junior	2023-08-24	Annually	6	0.31%
LIKHITHA.NS	Dividend Junior	2023-09-20	Annually	4	0.46%
GANESHHOUC.NS	Dividend Junior	2023-08-31	Sporadic	18	0.18%
APTUS.NS	Dividend Junior	2023-05-12	Semi-Annually	3	0.32%
TECHNOE.NS	Dividend Junior	2023-09-15	Annually	16	1.13%
ONGC.NS	Dividend Knight	2023-08-18	Semi-Annually	28	4.00%
IOC.NS	Dividend Knight	2023-07-28	Semi-Annually	28	5.08%
CRAFTSMAN.NS	Dividend Junior	2023-06-19	Annually	3	0.13%
SHANTIGEAR.NS	Dividend Junior	2023-07-11	Annually	23	1.02%
MANGCHEFER.NS	Dividend Junior	2023-09-18	Annually	17	1.18%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.182	1.500	6.35	9.53	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.214	1.500	8.73	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	142.88	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	16.08	2.00	4.64	9.28	[0 - 30]
freeCashFlowPerShareTTM	16.08	2.00	1.958	3.92	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.742	1.000	0.974	0.974	[0.2 - 0.8]
operatingProfitMarginTTM	0.241	1.000	7.18	7.18	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.37

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	37.54	1.000	6.31	0	[1 - 100]
returnOnEquityTTM	0.214	2.50	9.18	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	16.08	2.00	4.64	3.92	[0 - 30]
dividendYielPercentageTTM	1.869	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	16.08	2.00	4.64	9.28	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.115	1.500	5.90	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0502	1.000	-1.246	0	[0.1 - 0.5]
Total Score				5.25

Ajanta Pharma Limited

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.

Echtzeitaktualisierungen für Ajanta Pharma Limited [AJANTPHARM.NS]

Upcoming Earnings Alert

Ajanta Pharma Limited Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)